I respect your thoughts though you are someone who is sitting outside of the BOD. You have no idea of the conversations had with partners and or these investors. If you can come up with this scenario I'm sure Imugene had thought this through. They are also "invested" and want to get the best bang for their buck.
Do you have any expertise in immuno-oncology or biotech partnerships?
Ann: Imugene completes $90 M placement and launches $5 M SPP, page-242
-
- There are more pages in this discussion • 236 more messages in this thread...
You’re viewing a single post only. To view the entire thread just sign in or Join Now (FREE)
Add IMU (ASX) to my watchlist
 (20min delay)
|
|||||
|
Last
5.9¢ |
Change
0.005(9.26%) |
Mkt cap ! $433.6M | |||
| Open | High | Low | Value | Volume |
| 5.5¢ | 5.9¢ | 5.4¢ | $1.489M | 25.99M |
Buyers (Bids)
| No. | Vol. | Price($) |
|---|---|---|
| 2 | 35252 | 5.9¢ |
Sellers (Offers)
| Price($) | Vol. | No. |
|---|---|---|
| 6.0¢ | 1753430 | 24 |
View Market Depth
| Last trade - 16.10pm 12/07/2024 (20 minute delay) ? |
| IMU (ASX) Chart |